review of glp 1 GLP-1 GLP-1 agonists and changes in
Description
Injecting into muscle rather than subcutaneous tissue can alter absorption rates and reduce effectiveness
I keep an eye on this space because, despite considerable issues with nausea, vomiting, muscle loss, and even rare cases of sudden blindness, the GLP-1 RA drugs may offer the first real hope for patients with metabolic syndrome associated with chronic ulcers
3F) (two-way ANOVA with repeated measures)
M.et al (2011)
